Moderna Stock

• Moderna can meet 2023 COVID vaccine forecast, unlike Pfizer: analysts

  Around 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach US$2 billion in 2023 sales.

  World

  Nov 1, 2023
  
• New COVID shots effective against latest variant, Pfizer and Moderna say

  Pfizer said its updated COVID vaccine elicited a strong antibody response against BA.2.86 in a preclinical study. Moderna said its new shot was also effective against the variant.

  Health

  Sep 6, 2023
  
• Advertisement
• Merck, Moderna show progress on skin cancer vaccine using same technology as COVID shots

  The patient group that took the potential skin cancer vaccine and Keytruda saw a 44 per cent reduction in the risk of death or the cancer returning, the companies said.

  Health

  Dec 13, 2022
• Advertisement
• Moderna says its Omicron shots provide better protection than original COVID-19 jab

  Moderna, however, said levels of neutralizing antibody response dropped nearly five-fold against the emerging sub-variant BQ.1.1 when compared with BA.4/5.

  World

  Nov 14, 2022
• Moderna shares drop as company cuts COVID-19 vaccine sales forecast on supply woes

  Some U.S. pharmacies in September had reported that government supply of Moderna's updated shot remains limited, causing appointments for the product to vary across the country.

  World

  Nov 3, 2022
• Moderna to set up Africa’s first mRNA vaccine manufacturing facility

  Moderna said it expects to invest about $500 million in the Kenyan facility and supply as many as 500 million doses of mRNA vaccines to the continent each year.

  World

  Mar 7, 2022
• Moderna struggles with COVID-19 vaccine ramp-up, cuts 2021 sales forecast

  Moderna's sales target cut is in sharp contrast to that of larger rival Pfizer Inc, which earlier this week raised its sales forecast for its COVID-19 shot.

  Money

  Nov 4, 2021
• Moderna co-founder says Canada needs focused funds to grow domestic biotech

  Moderna's Canadian co-founder says politicians often try to be equitable with their funding pledges to hit every region of the country -- but it's not always the right strategy.

  Health

  Oct 28, 2021
• Advertisement
• U.S. IP waiver support rocks COVID-19 vaccine makers

  Pfizer, Moderna, Novavax and U.S. shares of BioNTech were down between four per cent and 10 per cent on Thursday.

  Money

  May 6, 2021